Valeant Launches $1B Private Senior Notes Offering

Valeant Pharmaceuticals International Inc. has launched a private offering of $1 billion in senior unsecured notes in an effort to refinance debt and fund potential future acquisitions, the Canadian drug giant...

Already a subscriber? Click here to view full article